Sarpogrelate
Alternative Names: Anplag; MCI-9042Latest Information Update: 12 Dec 2025
At a glance
- Originator Mitsubishi Chemical
- Developer Mitsubishi Chemical; Mitsubishi Tanabe Pharma Corporation
- Class Antiplatelets; Butyric acids; Dimethylamines; Succinates; Vascular disorder therapies
- Mechanism of Action Serotonin 5-HT2A receptor antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Arterial occlusive disorders
- Discontinued Cerebral infarction; Myocardial infarction; Pain; Raynaud's disease; Respiratory tract disorders; Stroke